| Schedule of reporting segment |
Segment information for prior periods has been recast to conform to the current year reportable segment structure. There were no intercompany transactions between the Company’s reportable segments during the years presented. Reportable segment information is presented below (in thousands): | | | | | | | | | Year ended December 31, 2025 | | Med Device | | | Clinic Service | | | Total | Revenue | $ | 62,180 | | $ | 86,977 | | $ | 149,157 | Cost of revenues | | 16,464 | | | 60,385 | | | 76,849 | Segment gross profit | $ | 45,716 | | $ | 26,592 | | $ | 72,308 | | | | | | | | | | Significant Segment Expense | | | | | | | | | Selling, General and Administrative | | | | | | | | | Direct | $ | 36,120 | | $ | 29,528 | | $ | 65,648 | | | | | | | | | | Research and development | | | | | | | | | Direct | | 6,353 | | | 231 | | | 6,584 | | | | | | | | | | Segment profit/(loss) | $ | 3,243 | | $ | (3,167) | | $ | 76 | | | | | | | | | | Unallocated expenses | | | | | | | | | General and Administrative | | | | | | | $ | 31,512 | Other income, net | | | | | | | | (716) | Interest expense | | | | | | | | 8,415 | | | | | | | | | | Net loss | | | | | | | $ | (39,135) | | | | | | | | | |
| | | | | | | | | Year ended December 31, 2024 | | Med Device | | | Clinic Service | | | Total | Revenue | $ | 70,445 | | $ | 4,445 | | $ | 74,890 | Cost of revenues | | 17,516 | | | 3,213 | | | 20,729 | Segment gross profit | $ | 52,929 | | $ | 1,232 | | $ | 54,161 | | | | | | | | | | Significant Segment Expense | | | | | | | | | Selling, General and Administrative | | | | | | | | | Direct | $ | 44,777 | | $ | 854 | | $ | 45,631 | | | | | | | | | | Research and development | | | | | | | | | Direct | | 12,758 | | | 13 | | | 12,771 | | | | | | | | | | Segment profit/(loss) | $ | (4,606) | | $ | 365 | | $ | (4,241) | | | | | | | | | | Unallocated expenses | | | | | | | | | General and Administrative | | | | | | | $ | 30,322 | Other income, net | | | | | | | | (2,549) | Interest expense | | | | | | | | 7,286 | Loss on extinguishment of debt | | | | | | | | 4,427 | | | | | | | | | | Net loss | | | | | | | $ | (43,727) | | | | | | | | | |
| | | | | | | | | Year ended December 31, 2023 | | Med Device | | | Clinic Service | | | Total | Revenue | $ | 71,348 | | $ | — | | $ | 71,348 | Cost of revenues | | 19,643 | | | — | | | 19,643 | Segment gross profit | $ | 51,705 | | $ | — | | $ | 51,705 | | | | | | | | | | Significant Segment Expense | | | | | | | | | Sales and marketing | | | | | | | | | Direct | $ | 47,318 | | $ | — | | $ | 47,318 | | | | | | | | | | Research and development | | | | | | | | | Direct | | 9,515 | | | — | | | 9,515 | | | | | | | | | | Segment loss | $ | (5,128) | | $ | — | | $ | (5,128) | | | | | | | | | | Unallocated expenses | | | | | | | | | General and administrative | | | | | | | | 25,426 | Other income, net | | | | | | | $ | (5,789) | Interest expense | | | | | | | | 5,424 | | | | | | | | | | Net loss | | | | | | | $ | (30,189) | | | | | | | | | |
|